cirrhosis diagnosis. Furthermore, the posttreatment parameters of the AFP level 1 tolica del Sacro Cuore, Rome, Italy. month after PEI and recurrence of HCC in the same liver segment were also 2 Divisione di Gastroenterologia, IRCCS Casa evaluated. Sollievo della Sofferenza, San Giovanni Rotondo #
IMP 1404 Prognostic factors for survival in cirrhotic patients with hepatocellular carcinoma (HCC) treated by percutaneous ethanol injection (PEI)
โ Scribed by Concetta Trombino; Maurizio Pompili; Eugenio Caturelli; Maria R. Villani; Gian P. Lorenzelli; Gian L. Rapaccini; Giovanni Gasbarrini
- Book ID
- 104324897
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 146 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0301-5629
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
For "early" hepatocellular carcinoma (HCC), surgery, orthotopic liver transplantation (OLT) and percutaneous ethanol injection (PEI) improve the natural history of the disease. We performed a retrospective study to evaluate the outcome of patients with cirrhosis and early HCC treated by PEI (n = 417
## Background: The objective of this study was to identify clinical, biochemical, ultrasound, and/or pathologic parameters capable of predicting survival in a cohort of patients with well compensated cirrhosis and small hepatocellular carcinoma (hcc) who were treated with percutaneous ethanol injec